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j ourna l homepage: www.e lsev ie r .com/ locate /bbad isPrefaceRole of the nucleolus in human diseasesThe nucleolus is a subnuclear structure which is the center of ribo-
somal biogenesis and a hot spot of RNA-polymerase-I-mediated tran-
scription. Hence, the nucleolus is critical for protein synthesis. In
addition, by sequestering regulators of cell cycle, differentiation and
stress response, the nucleolus contributes to intracellular signaling. It
also appears that the nucleolus plays an important role in processing
of various non-ribosomal RNAs and in the maintenance of heterochro-
matin. Disruption of the nucleolus is critical for pathological cascades
that are activated by inborn errors of ribosomal biogenesis. In addition,
nucleolar insufﬁciency may play a role in degenerative pathologies of
the nervous system or the heart. Last but not least, the nucleolus is
often hijacked by tumors or viruses to support growth of transformed
cells or viral replication, respectively. This special issue highlights recent
progress in mechanistic understanding of the nucleolar involvement in
these diverse pathologies.
The ﬁrst three articles of the issue review the literature on pathogen-
esis of inborn errors of ribosomal biogenesis that are also known as
ribosomopathies. First, Samuel Sondalle and Susan Baserga present
newly discovered disease-associated defects in the synthesis of the
small ribosomal subunit. Next, Steven Ellis discusses the role of nucleo-
lar disruption in the pathogenesis of Diamond Blackfan anemia that is
caused bymutations affecting large- or small ribosomal subunit produc-
tion. Finally, Paul Trainor and AmyMerrill write about ribosomopathies
that affect skeletal development. The next three articles review recent
ﬁndings that implicate the nucleolus in neurodegenerative diseases.
Ho Tsoi and Edwin Chan discuss the contribution of the nucleolar stress
to neurotoxicity of CAG-expanded transcripts in such neurodegenera-
tive disease as spinocerebellar ataxias or Huntington's disease. Junghee
Lee, Hoon Ryu and colleagues focus on the role of disrupted post-
translational regulation of the nucleolar transcription factor UBF by
Huntington's disease associated poly-Q expansions of huntingtin.
Rosanna Parlato and Brigit Liss present the case for the nucleolar stress
in Parkinson's disease. Next, Nirmala Hariharan andMark Sussman pro-
vide aminireview on the emerging role of the nucleolus in cardiovascu-
lar diseases. While existence of dangerous liaisons between the
nucleolus and cancer has been recognized long time ago, reports on
their underlying mechanisms and their therapeutic targeting have
emerged only recently. Three articles present some of these exciting
developments. First, Sladana Bursac, Sinisa Volarevic and colleagues re-
view recent advances on the ribosomal biogenesis checkpoint that con-
trols the tumor suppressor p53. Second, Leonard Maggi, Jason Weberhttp://dx.doi.org/10.1016/j.bbadis.2014.03.004
0925-4439/© 2014 Elsevier B.V. All rights reserved.and colleagues discuss the nucleolar anti-cancer mechanisms that are
engaged by another tumor suppressor, ARF. Third, Jaclyn Quinn, Ross
Hannan and colleagues focus on therapeutic targeting of the nucleolus
in cancer. The series of review articles closes with a paper by Anna
Salvetti and Anna Greco on the role of the nucleolus in viral infections.
Finally, the issue includes two original contributions that probe nucleo-
lar involvement in pathologies of the nervous system. Ana Palanca,
Miguel Lafarga and colleagues demonstrate increased activity of the
nucleolus in a model of chemotherapy-induced neuropathy. Justin
Hallgren, Michal Hetman and co-workers report instability of nucleolar
rRNA genes in dementia with Lewy bodies. That closing paper also pro-
vides an extensive review of literature on the importance of nucleolar
DNA stability for cellular homeostasis.
While nucleolar function and dysfunction have been subjects of
several excellent reviews, this special issue has been designed to cre-
ate a uniquely broad insight into the rapidly expanding ﬁeld of
“nucleolopathies”. The editor and the authors hope that the resulting
collection of articles will provide a useful guide to that ﬁeld. We also
hope to inspire future research expanding our understanding of the
nucleolar involvement in diseases.
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